TransRadial Education and Therapeutics (TREAT): Shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: A report from the Cardiac Safety Research Consortium

American Heart Journal

Volumn 165, Issue 3, 2013, Pages

  Hess, Connie N ^a   Rao, Sunil V ^a   Kong, David F ^a   Miller, Julie M ^b   Anstrom, Kevin J ^a   Bertrand, Olivier F ^c   Collet, Jean Philippe ^d   Effron, Mark B ^e   Eloff, Benjamin C ^f   Fadiran, Emmanuel O ^f   Farb, Andrew ^f   Gilchrist, Ian C ^g   Holmes, David R ^h   Jacobs, Alice K ⁱ   Kaul, Prashant ^j   Newby, L Kristin ^a   Rutledge, David R ^k   Tavris, Dale R ^f   Tsai, Thomas T ^l   White, Roseann M ^k   Peterson, Eric D ^a   Krucoff, Mitchell W ^a,m   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d Institut de Cardiologie   (France)

^e Lilly USA   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h MAYO CLINIC   (United States)

ⁱ BOSTON MEDICAL CENTER   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k ABBOTT VASCULAR   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; HIRULOG;

ARTICLE; BLEEDING; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HOSPITALIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STENT THROMBOSIS; VASCULAR ACCESS;

EID: 84875162893     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.09.008     Document Type: Review

References (47)

1. J.C.C. Talbot, J.K. Aronson, and M.D.B. Stephens Stephens' detection and evaluation of adverse drug reactions: principles and practice 2011 John Wiley & Sons Chichester, West Sussex, UK
2. M. Fung Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets - 1960 to 1999 Drug Inf J 35 2001 293 317
3. J.P. Piccini, D.J. Whellan, and B.R. Berridge Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the critical path initiative Am Heart J 158 2009 317 326
4. FDA Innovation or stagnation: challenge and opportunity on the critical path to new medical products 2004 Food and Drug Administration, U.S. Department of Health and Human Services Washington, DC
5. S.M. Al-Khatib, H. Calkins, and B.C. Eloff Developing the safety of atrial fibrillation ablation registry initiative (safari) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "incubator" think tank Am Heart J 160 2010 619 626
6. Mauri L, Kereiakes DJ, Normand SL, et al. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J. 2010;160:1035-1041, 1041 e1031
7. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 e574 e651
8. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
9. M.A. Lauer, J.A. Karweit, and E.F. Cascade Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997 Am J Cardiol 89 2002 924 929
10. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
11. J.J. Popma, L.F. Satler, and A.D. Pichard Vascular complications after balloon and new device angioplasty Circulation 88 1993 1569 1578
12. W.B. Batchelor, K.J. Anstrom, and L.H. Muhlbaier Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration J Am Coll Cardiol 36 2000 723 730
13. K. Buresly, M.J. Eisenberg, and X. Zhang Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction Arch Intern Med 165 2005 784 789
14. N. Shehab, L.S. Sperling, and S.R. Kegler National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin Arch Intern Med 170 2010 1926 1933
15. S.V. Rao, M.G. Cohen, and D.E. Kandzari The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions J Am Coll Cardiol 55 2010 2187 2195
16. F.W. Verheugt, S.R. Steinhubl, and M. Hamon Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention JACC Cardiovasc Interv 4 2011 191 197
17. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the acuity trial J Am Coll Cardiol 49 2007 1362 1368
18. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
19. B.J. Doyle, C.S. Rihal, and D.A. Gastineau Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
20. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
21. S.V. Rao, F.S. Ou, and T.Y. Wang Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry JACC Cardiovasc Interv 1 2008 379 386
22. A.J. Lansky, R. Mehran, and E. Cristea Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the acuity trial) Am J Cardiol 103 2009 1196 1203
23. Duvernoy CS, Smith DE, Manohar P, et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the blue cross blue shield of michigan cardiovascular consortium (bmc2) percutaneous coronary intervention registry. American Heart Journal. 2010;159:677-683 e671
24. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
25. K.P. Alexander, A.Y. Chen, and L.K. Newby Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative Circulation 114 2006 1380 1387
26. H. Eggebrecht, C. von Birgelen, and C. Naber Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device J Invasive Cardiol 16 2004 247 250
27. D.R. Tavris, B.A. Gallauresi, and B. Lin Risk of local adverse events following cardiac catheterization by hemostasis device use and gender J Invasive Cardiol 16 2004 459 464
28. B. Ahmed, W.D. Piper, and D. Malenka Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv 2 2009 423 429
29. E.D. Peterson, A.J. Lansky, and J. Kramer Effect of gender on the outcomes of contemporary percutaneous coronary intervention Am J Cardiol 88 2001 359 364
30. E. Argulian, A.D. Patel, and J.L. Abramson Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions Am J Cardiol 98 2006 48 53
31. H. Tizon-Marcos, O.F. Bertrand, and J. Rodes-Cabau Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes Am Heart J 157 2009 740 745
32. S.P. Marso, A.P. Amin, and J.A. House Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
33. S.S. Jolly, S. Amlani, and M. Hamon Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
34. P. Agostoni, G.G. Biondi-Zoccai, and M.L. de Benedictis Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials J Am Coll Cardiol 44 2004 349 356
35. S.S. Jolly, S. Yusuf, and J. Cairns Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
36. C.J. Cooper, R.A. El-Shiekh, and D.J. Cohen Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison Am Heart J 138 1999 430 436
37. A.J. Chase, E.B. Fretz, and W.P. Warburton Association of the arterial access site at angioplasty with transfusion and mortality: the m.O.R.T.A.L study (Mortality Benefit of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
38. Y. Louvard, T. Lefevre, and M.C. Morice Radial approach: what about the learning curve? Cathet Cardiovasc Diagn 42 1997 467 468
39. M. Mercuri, S. Mehta, and C. Xie Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure JACC Cardiovasc Interv 4 2011 347 352
40. Y. Louvard, T. Lefevre, and A. Allain Coronary angiography through the radial or the femoral approach: the CARAFE study Catheter Cardiovasc Interv 52 2001 181 187
41. W.T. Ball, W. Sharieff, and S.S. Jolly Characterization of operator learning curve for transradial coronary interventions Circ Cardiovasc Interv 4 2011 336 341
42. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
43. O. Barthelemy, J. Silvain, and D. Brieger Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center Catheter Cardiovasc Interv 79 2012 104 112
44. A. Vorobcsuk, A. Konyi, and D. Aradi Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction systematic overview and meta-analysis Am Heart J 158 2009 814 821
45. D. Joyal, O.F. Bertrand, and S. Rinfret Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention Am J Cardiol 109 2012 813 818
46. E. Romagnoli, G. Biondi-Zoccai, and A. Sciahbasi Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study J Am Coll Cardiol 2012 [Epub ahead of print].
47. S. Pancholy, J. Coppola, and T. Patel Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization Catheter Cardiovasc Interv 72 2008 335 340